Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease

Yue Liu; Hui-jun Yin; Ke-ji Chen

doi:10.1007/s11655-011-0814-z

Your Location：

Home >

Browse articles >

Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease

OriginalPaper | Updated：2021-08-27

- Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease
- Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease
- 中国结合医学杂志（英文版） 2011年17卷第8期页码：587-592
- Affiliations：
  
  Department of Cardiovascular Disease, Xiyuan Hospital, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (No. 81073086)
- DOI：10.1007/s11655-011-0814-z
  中图分类号：
- 纸质出版日期：2011，
  
  网络出版日期：2011-8-9，
Scan for full text
Liu, Y., Yin, Hj. & Chen, Kj. Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease., Chin. J. Integr. Med. 17, 587 (2011). https://doi.org/10.1007/s11655-011-0814-z

Yue Liu, Hui-jun Yin, Ke-ji Chen. Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease[J]. Chinese Journal of Integrative Medicine, 2011,17(8):587-592.
Liu, Y., Yin, Hj. & Chen, Kj. Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease., Chin. J. Integr. Med. 17, 587 (2011). https://doi.org/10.1007/s11655-011-0814-z DOI：

Yue Liu, Hui-jun Yin, Ke-ji Chen. Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease[J]. Chinese Journal of Integrative Medicine, 2011,17(8):587-592. DOI： 10.1007/s11655-011-0814-z.

摘要

To study the distribution of gelsolin in human platelet and plasma

and the association with blood-stasis syndrome (BSS) of coronary heart disease (CHD). Sixty patients with CHD (30 in BSS group and 30 in non-BSS group) and 30 healthy subjects (control group) were included in this study. The classification of the syndrome was based on clinical symptoms and signs. Gelsolin concentration in platelet rich plasma (PRP)

platelet poor plasma (PPP)

filamentous actin (F-actin) and group-specific component globulin (Gc-globulin) of PPP were determined by enzyme-linked immunosorbent assay (ELISA). The fluorescence intensity of CD62p and cytoplasmic calcium ([Ca2+]i) in human platelets of patients and healthy persons was measured with flow cytometry. Compared with the control group

gelsolin in PRP of the BSS group increased significantly (P<0.01)

while that in PPP of the BSS and non-BSS groups decreased markedly (P<0.05)

the CD62p

[Ca2+]i of platelet

F-actin

and Gc-globulin of the BSS and non-BSS groups increased significantly (P<0.01). Compared with the non-BSS group

the gelsolin concentration in PRP of BSS group increased significantly (P<0.01)

the [Ca2+]i of platelet of the BSS group increased markedly (P<0.01)

while the F-actin and Gc-globulin of the BSS group had no statistical defference (P>0.05). Gelsolin concentration in PRP was increased and accompanied by the elevated [Ca2+]i of platelet in CHD with BSS

while gelsolin in PPP were lowered markedly. We speculate that plasma gelsolin may clear F-actin from circulation

thus resulting in depletion of plasma gelsolin significantly. This

in addition to the increased calcium influx of platelets

may lead to the gelsolin abnormal expression on platelets during the process of BSS in CHD. Therefore

platelet gelsolin may serve as a new potential biomarker and a therapeutic target of BSS in CHD.

Abstract

To study the distribution of gelsolin in human platelet and plasma

platelet poor plasma (PPP)

gelsolin in PRP of the BSS group increased significantly (P<0.01)

while that in PPP of the BSS and non-BSS groups decreased markedly (P<0.05)

the CD62p

[Ca2+]i of platelet

F-actin

and Gc-globulin of the BSS and non-BSS groups increased significantly (P<0.01). Compared with the non-BSS group

the gelsolin concentration in PRP of BSS group increased significantly (P<0.01)

the [Ca2+]i of platelet of the BSS group increased markedly (P<0.01)

while gelsolin in PPP were lowered markedly. We speculate that plasma gelsolin may clear F-actin from circulation

thus resulting in depletion of plasma gelsolin significantly. This

in addition to the increased calcium influx of platelets

may lead to the gelsolin abnormal expression on platelets during the process of BSS in CHD. Therefore

platelet gelsolin may serve as a new potential biomarker and a therapeutic target of BSS in CHD.

关键词

gelsolinfilamentous actincoronary heart diseaseBlood Stasis Syndromeplatelet activation

Keywords

gelsolinfilamentous actincoronary heart diseaseBlood Stasis Syndromeplatelet activation

references

Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482–2494.

Moliterno DJ. Advances in antiplatelet therapy for ACS and PCI. J Interv Cardiol 2008;21(S11):S18–S24.

García A. Clinical proteomics in platelet research: challenges ahead. J Thromb Haemost 2010;8:1784–1785.

Thiele T, Steil L, Gebhard S, Scharf C, Hammer E, Brigulla M, et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007;47:1221–1233.

Banfi C, Brioschi M, Marenzi G, De Metrio M, Camera M, Mussoni L, et al. Proteome of platelets in patients with coronary artery disease. Exp Hematol 2010;38:341–350.

Senzel L, Gnatenko DV, Bahou WF. The platelet proteome. Curr Opin Hematol 2009;16:329–333.

Chen KJ, Xue M, Yin HJ. The relationship between platelet activation and coronary heart disease and blood-stasis syndrome. J Capital Med Univ (Chin) 2008;29:266–269.

Xue M, Chen KJ, Yin HJ. Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of bloodstasis syndrome. Chin J Integr Med 2008;14:267–273.

Li XF, Jiang YR, Wu CF, Chen KJ, Yin HJ. Study on the correlation between platelet function proteins and symptom complex in coronary heart disease. Mol Cardiol China (Chin) 2009;9:326–331.

Chen HZ, ed. Practical internal medicine. 12th ed. Beijing: People’s Medical Publishing House; 2005:1472–1473.

Society of Cardiology, Chinese Association of the Integrative Medicine. The diagnostic criteria of Chinese medicine in coronary heart disease. Chin J Integr Tradit West Med (Chin) 1991;11:257.

Zhuang MM, Wen YX, Liu SL, Hong XP. Determination of the level of cytopplasmic free calcium in human platelets with flow cytometry. J Xi’an Jiaotong Univ (Med Sci, Chin) 2005;26:508–510.

Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440–3450.

Brydon L, Magid K, Steptoe A. Platelets, coronary heart disease, and stress. Brain Behav Immun 2006;20:113–119.

Antoniades C, Bakogiannis C, Tousoulis D, Demosthenous M, Marinou K, Stefanadis C. Platelet activation in atherogenesis associated with low-grade inflammation. Inflamm Allergy Drug Targets 2010;9:334–345.

Yin HL, Stossel TP. Control of cytop lasmic actin gelsol transformation by gelsolin, a calcium dependent regulatory protein. Nature 1979;281:583–586.

Spinardi L, Witke W. Gelsolin and diseases. Subcell Biochem 2007;45:55–69.

Vasconcellos CA, Lind SE. Coordinated inhibition of actin-induced platelet aggregation by plasma gelsolin and vitamin D-binding protein. Blood 1997;82:3648–3657.

Lee WM, Galbraith RM. The extracellular actin scavenger systern and actin toxicity. N Engl J Med 1992;326:1335–1341.

Suhler E, Lin W, Yin HL. Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock and myonecrosis. Crit Care Med 1997;25:594–598.

Kato M, Kambe M, Kajiyama G. Increased cytosolic free Mg2+ and Ca2+ in platelets of patients with vasospastic. Am J Physiol 1998;274:548–554.

Fujinishi A, Takahara K, Ohba C, Nakashima Y, Kuroiwa A. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease. Angiology 1997;48:515–521.

FULL TEXT LINK

More>

浏览量

870

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Blood stasis syndrome of coronary heart disease: A perspective of modern medicine

Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches

Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome

Exploration on significance of platelet cd62p, cdp63 determination in type 2 diabetes mellitus patients with blood stasis syndrome

Association of platelet-activating factor receptor gene rs5938 (G/T) and rs313152 (T/C) polymorphisms with coronary heart disease and blood stasis syndrome in a Chinese Han population